Bandingkan Harga & Kinerja Merck Tbk. (MERK) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Merck Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Merck Tbk. diperdagangkan di Rp3.890 (kapitalisasi pasar 1,75 T, volume 24 jam 23,8 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 164,65 M, volume 24 jam 43,9 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 10,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (43,9 rb vs 23,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,75 T | 164,65 M |
Volume | 23,8 rb | 43,9 rb |
Lot | 238 | 439 |
Perputaran | 92,73 jt | 10,6 jt |
Harga Rata-rata | 3.896,01 | 241,43 |
Nilai Transaksi | 92,73 jt | 10,6 jt |
Harga Ekuilibrium Indikatif | 3.930 | 238 |
Volume Ekuilibrium Indikatif | 3 | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
